Want to join the conversation?
$ALXN 2Q15 Call: During 2Q15, ALXN both announced and closed the acquisition of Synageva, while continuing to execute strong growth in the core Soliris business. Delivered important regulatory milestones toward upcoming global launches of Strensiq and Kanuma, which both will further diversify and accelerate the company’s growth.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?